Double demonstration of oncogenic high risk human papilloma virus DNA and HPV-E7 protein in oral cancers

International Journal of Immunopathology and Pharmacology

Volumn 24, Issue , 2011, Pages 95-101

  Pannone, G ^a   Santoro, A ^a   Carinci, F ^b   Bufo, P ^a,c   Papagerakis, S M ^d   Rubini, C ^e   Campisi, G ^f   Giovannelli, L ^f   Contaldo, M ^g   Serpico, R ^g   Mazzotta, M ^a   Lo Muzio, L ^a,c  

^a UNIVERSITY OF FOGGIA   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c REFERRAL CANCER CENTER OF BASILICATA   (Italy)

^d UNIVERSITY OF MICHIGAN   (United States)

^e UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^f Department of Oral Pathology   (Italy)

^g SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

E 7; HPV; oncogenic proteins; oral carcinogenesis; OSCC

Indexed keywords

PROTEIN E7; PROTEIN P53; VIRUS DNA; VIRUS PROTEIN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RISK; CELL IMMORTALIZATION; CLINICAL ARTICLE; DNA EXTRACTION; DNA INTEGRATION; FEMALE; GENE EXPRESSION; GENE SEQUENCE; GENOTYPE; GIANT CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH CANCER; NONHUMAN; OUTCOME ASSESSMENT; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; WART VIRUS; CANCER STAGING; GENETICS; METABOLISM; MOUTH TUMOR; PAPILLOMA VIRUS; PATHOLOGY; SQUAMOUS CELL CARCINOMA; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS E7 PROTEINS; PAPILLOMAVIRUS INFECTIONS;

EID: 84859187007     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/03946320110240S217     Document Type: Article

References (20)

1. Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Forastiere A, Gillison ML,. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008; 100: 261-9.
2. Campisi G, Giovannelli L,. Controversies surrounding human papilloma virus infection, head & neck vs oral cancer, implications for prophylaxis and treatment. Head Neck Oncol 2009; 1: 8.
3. Szarka K, Tar I, Feher E, Gall T, Kis A, Toth ED, Boda R, Marton I, Gergely L,. Progressive increase of human papillomavirus carriage rates in potentially malignant and malignant oral disorders with increasing malignant potential. Oral Microbiol Immunol 2009; 24: 314-8.
4. Martin CM, Astbury K, McEvoy L, O'Toole S, Sheils O, O'Leary JJ,. Gene expression profiling in cervical cancer: Identification of novel markers for disease diagnosis and therapy. Methods Mol Biol 2009; 511: 333-59.
5. Rampias T, Sasaki C, Weinberger P, Psyrri A,. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells. J Natl Cancer Inst 2009; 101: 412-23.
6. Preville X, Ladant D, Timmerman B, Leclerc C,. Eradication of established tumors by vaccination with recombinant Bordetella pertussis adenylate cyclase carrying the human papillomavirus 16 E7 oncoprotein. Cancer Res 2005; 65: 641-9.
7. Shillitoe EJ,. The role of viruses in squamous cell carcinoma of the oropharyngeal mucosa. Oral Oncol 2009; 45: 351-5.
8. Poh CF, Ng S, Berean KW, Williams PM, Rosin MP, Zhang L,. Biopsy and histopathologic diagnosis of oral premalignant and malignant lesions. J Can Dent Assoc 2008; 74: 283-8.
9. de Araujo RF Jr., Barboza CA, Clebis NK, de Moura SA, Costa Ade L Lopes,. Prognostic significance of the anatomical location and TNM clinical classification in oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal 2008; 13: E344-7.
10. Campisi G, Di Fede O, Giovannelli L, Capra G, Greco I, Calvino F, Florena A Maria, Lo Muzio L,. Use of fuzzy neural networks in modeling relationships of HPV infection with apoptotic and proliferation markers in potentially malignant oral lesions. Oral Oncol 2005; 41: 994-1004.
11. Morshed K, Korobowicz E, Szymanski M, Skomra D, Golabek W,. Immunohistochemical demonstration of multiple HPV types in laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol 2005; 262: 917-20.
12. Handa K, Yugawa T, Narisawa-Saito M, Ohno S, Fujita M, Kiyono T,. E6AP-dependent degradation of DLG4/PSD95 by high-risk human papillomavirus type 18 E6 protein. J Virol 2007; 81: 1379-89.
13. Jo S, Juhasz A, Zhang K, Ruel C, Loera S, Wilczynski SP, Yen Y, Liu X, Ellenhorn J, Lim D, Paz B, Somlo G, Vora N, Shibata S,. Human papillomavirus infection as a prognostic factor in oropharyngeal squamous cell carcinomas treated in a prospective phase II clinical trial. Anticancer Res 2009; 29: 1467-74.
14. Chaudhary AK, Singh M, Sundaram S, Mehrotra R,. Role of human papillomavirus and its detection in potentially malignant and malignant head and neck lesions: Updated review. Head Neck Oncol 2009; 1: 22.
15. Kadaja M, Isok-Paas H, Laos T, Ustav E, Ustav M,. Mechanism of genomic instability in cells infected with the high-risk human papillomaviruses. PLoS Pathog 2009; 5: el000397.
16. Hennessey PT, Westra WH, Califano JA,. Human papillomavirus and head and neck squamous cell carcinoma: Recent evidence and clinical implications. J Dent Res 2009; 88: 300-6.
17. Tachezy R, Klozar J, Rubenstein L, Smith E, Salakova M, Smahelova J, Ludvikova V, Rotnaglova E, Kodet R, Hamsikova E,. Demographic and risk factors in patients with head and neck tumors. J Med Virol 2009; 81: 878-87.
18. Petersen PE,. Oral cancer prevention and control-the approach of the World Health Organization. Oral Oncol 2009; 45: 454-60.
19. Kreimer AR, Clifford GM, Boyle P, Franceschi S,. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: A systematic review. Cancer Epidemiol Biomarkers Prev 2005; 14: 467-75.
20. Scapoli L, Palmieri A, Rubini C, Martinelli M, Spinelli G, Ionna F, Carinci F,. Low prevalence of human papillomavirus in squamous-cell carcinoma limited to oral cavity proper. Mod Pathol 2009; 22: 366-72.